3-(4-BROMOPHENYL)-5H,6H-IMIDAZO(2,1-B)(1,3)THIAZOLE HYDROBROMIDE
UNII FD7N9AH5KB

Substance Identification & Data

This profile provides standardized clinical and technical data for 3-(4-bromophenyl)-5h,6h-imidazo(2,1-b)(1,3)thiazole Hydrobromide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FD7N9AH5KB.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 36104-03-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

FD7N9AH5KB

CAS Registry Number

36104-03-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

3-(4-BROMOPHENYL)-5H,6H-IMIDAZO(2,1-B)(1,3)THIAZOLE HYDROBROMIDE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C11H9BrN2S.BrH

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

MSLXFUADXRMQEA-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

2844922

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

S1C=2N(C(=C1)c3ccc(cc3)Br)CCN2.Br

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for 3-(4-bromophenyl)-5h,6h-imidazo(2,1-b)(1,3)thiazole Hydrobromide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.